These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16897351)

  • 21. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
    Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS
    J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving treatment adherence in drug abusers who are HIV-positive.
    Malone SB; Osborne JJ
    Lippincotts Case Manag; 2000; 5(6):236-45; quiz 245-7. PubMed ID: 16398004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal recall period and response task for self-reported HIV medication adherence.
    Lu M; Safren SA; Skolnik PR; Rogers WH; Coady W; Hardy H; Wilson IB
    AIDS Behav; 2008 Jan; 12(1):86-94. PubMed ID: 17577653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.
    Ware NC; Wyatt MA; Tugenberg T
    Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
    Cohn SE; Umbleja T; Mrus J; Bardeguez AD; Andersen JW; Chesney MA
    AIDS Patient Care STDS; 2008 Jan; 22(1):29-40. PubMed ID: 18442305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices.
    Kalichman SC; Cain D; Cherry C; Kalichman M; Pope H
    AIDS Patient Care STDS; 2005 Dec; 19(12):833-9. PubMed ID: 16375615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
    Teixeira C; Dourado Mde L; Santos MP; Brites C
    AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
    Lucas GM; Griswold M; Gebo KA; Keruly J; Chaisson RE; Moore RD
    Am J Epidemiol; 2006 Mar; 163(5):412-20. PubMed ID: 16394200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations in patterns of highly active antiretroviral therapy (HAART) adherence.
    Levine AJ; Hinkin CH; Castellon SA; Mason KI; Lam MN; Perkins A; Robinet M; Longshore D; Newton T; Myers H; Durvasula RS; Hardy DJ
    AIDS Behav; 2005 Sep; 9(3):355-62. PubMed ID: 16088365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electronic monitoring: adherence assessment or intervention?
    Wagner GJ; Ghosh-Dastidar B
    HIV Clin Trials; 2002; 3(1):45-51. PubMed ID: 11819185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations.
    Bova CA; Fennie KP; Knafl GJ; Dieckhaus KD; Watrous E; Williams AB
    AIDS Behav; 2005 Mar; 9(1):103-10. PubMed ID: 15812617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.
    Llabre MM; Weaver KE; Durán RE; Antoni MH; McPherson-Baker S; Schneiderman N
    AIDS Patient Care STDS; 2006 Oct; 20(10):701-11. PubMed ID: 17052140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.